Publication | Closed Access
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group.
360
Citations
11
References
1998
Year
Adjuvant IFNalpha2a treatment diminishes the occurrence of metastases and thus prolongs disease-free survival in resected primary stage II cutaneous melanoma patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1